Abdominal aortic aneurysm (AAA) is one of the major vascular diseases caused by atherosclerosis. Because treatment for AAA mainly consists of surgery to prevent deaths from AAA rupture and there is a conspicuous absence of alternative therapeutic strategies, the development of minimally invasive treatment is needed. To develop a novel therapeutic approach, we examined the simultaneous inhibition of the transcription factors NFkB and ets, which regulate inflammation and matrix degradation, in a rabbit AAA model. In this study, we employed chimeric decoy oligodeoxynucleotides (ODN), containing the consensus sequences of both the NFkB-and ets-binding sites, to inhibit both the transcription factors simultaneously. Using a delivery sheet, we examined the inhibitory effect of chimeric decoy ODN on aortic dilatation. Ultrasound and angiographic analysis demonstrated that treatment with chimeric decoy ODN significantly prevented the progression of elastase-induced aortic dilatation. The inhibitory effect of chimeric decoy ODN on aortic dilatation was also confirmed by histological studies. Treatment with chimeric decoy ODN reduced the activities of matrix metalloproteinase (MMP)-2 and MMP-9 and markedly inhibited the proteolysis of elastin as compared to scrambled decoy ODN. Interestingly, treatment with chimeric decoy ODN also suppressed VCAM-1 and MCP-1 gene expression, leading to inhibition of macrophage infiltration in the adventitia and media. The present study in a rabbit model provides a novel strategy to treat AAA by the simultaneous inhibition of both NFkB and ets using chimeric decoy ODN. Further modification of chimeric decoy ODN would be useful to treat AAA as a decoy-based therapy. Gene Therapy (2006) 13, 695-704.
Abdominal aortic aneurysm (AAA) is one of the major vascular diseases caused by atherosclerosis. Because treatment for AAA mainly consists of surgery to prevent deaths from AAA rupture and there is a conspicuous absence of alternative therapeutic strategies, the development of minimally invasive treatment is needed. To develop a novel therapeutic approach, we examined the simultaneous inhibition of the transcription factors NFkB and ets, which regulate inflammation and matrix degradation, in a rabbit AAA model. In this study, we employed chimeric decoy oligodeoxynucleotides (ODN), containing the consensus sequences of both the NFkB-and ets-binding sites, to inhibit both the transcription factors simultaneously. Using a delivery sheet, we examined the inhibitory effect of chimeric decoy ODN on aortic dilatation. Ultrasound and angiographic analysis demonstrated that treatment with chimeric decoy ODN significantly prevented the progression of elastase-induced aortic dilatation. The inhibitory effect of chimeric decoy ODN on aortic dilatation was also confirmed by histological studies. Treatment with chimeric decoy ODN reduced the activities of matrix metalloproteinase (MMP)-2 and MMP-9 and markedly inhibited the proteolysis of elastin as compared to scrambled decoy ODN. Interestingly, treatment with chimeric decoy ODN also suppressed VCAM-1 and MCP-1 gene expression, leading to inhibition of macrophage infiltration in the adventitia and media. The present study in a rabbit model provides a novel strategy to treat AAA by the simultaneous inhibition of both NFkB and ets using chimeric decoy ODN.
Introduction
Abdominal aortic aneurysm (AAA) is a common degenerative condition associated with aging and atherosclerosis. 1 Although elective surgical repair is an effective approach to prevent deaths from AAA rupture, there is a conspicuous absence of alternative therapeutic strategies for this disease. 2 The current pharmacological agents, propranolol, 3 indomethacin, 4 and angiotensin-converting enzyme inhibitors, 5 are relatively limited, since they are useful only to inhibit the progression of aneurysms including intracranial aneurysms. Thus, it is important to develop novel therapeutic approaches to prevent the development of AAA in clinical settings. Human aneurysm tissues are characterized by destructive remodeling of the elastic media and outer aortic wall. From this viewpoint, recent investigations have emphasized disease mechanisms involving chronic aortic wall inflammation and the progressive degradation of fibrillar matrix proteins. 6, 7 Although elastic fibers normally maintain the structure of the vascular wall against hemodynamic stress, proteolytic degradation induces remodeling of extracellular matrix, resulting in aneurysmal development and finally rupture. Degradation of local extracellular matrix is considered to occur through one or more of the matrix metalloproteinases (MMPs). Several MMPs have been focused on in AAA, including four that degrade elastic fibers (MMP-2, -7, -9, and -12), several that degrade interstitial collagen (MMP-1, -2, -8, -13, and -14), and others that degrade denatured collagen (MMP-2 and -9). [8] [9] [10] [11] [12] [13] [14] Evidence of resistance to AAA in mice lacking MMP-2 or -9 supports an important role of MMPs. 15, 16 Also, inflammation, which is temporally associated with disruption of the orderly lamellar structure of the aortic media, appears to play a fundamental role in MMP production and AAA development. Studies of human AAA tissue have shown extensive inflammatory infiltrates in both the media and adventitia. Widely used experimental models of AAA rely on local induction of an intense inflammatory response, 17, 18 which precedes a period of gradual aortic dilatation. Attenuation of the inflammatory response in animal models inhibits dilatation, whereas augmenting the response increases the frequency and size of aneurysms. 19, 20 Since inflammation and matrix degradation contribute to the progression of AAA, they are suitable molecular targets in developing new treatment for AAA. To develop a new therapeutic approach, we focused on the transcription factors NFkB and ets. In addition to mediating inflammatory changes, NFkB regulates the transcription of MMP-1, MMP-2, MMP-3, and MMP-9. [21] [22] [23] In contrast, members of the ets family play important roles in regulating gene expression in response to multiple developmental and mitogenic signals, and ets is also known to be a regulator of transcription of MMP-1, MMP-2, and MMP-9. Also, our previous data demonstrated that NFkB was expressed mainly in the adventitia and intima in specimens from human AAA, and that binding activity of NFkB and ets was induced in the neck of human aneurysms. 24, 25 Indeed, we have previously reported that inhibition of both NFkB and ets activation using decoy oligodeoxynucleotides (ODN) inhibited the development of AAA in a rat model. 25 Therefore, decoybased treatment represents a useful approach to treat AAA, with the prospect of clinical therapy. In this study, to consider the clinical usage of this strategy, we demonstrated successful treatment of AAA using chimeric decoy ODN against NFkB and ets in a rabbit model as a preclinical study (Figure 1 ).
Results

Prevention of development of AAA by chimeric decoy ODN in rabbit model
To confirm the successful transfer of decoy ODN into the aorta of rabbits, we initially transfected FITC-labeled decoy ODN using a delivery sheet. Fluorescence could be detected mainly in the adventitia and part of the media of rabbit aorta on day 1 and day 14 after wrapping ( Figure 2 ). Vessels transfected with non-FITC-labeled decoy ODN revealed no specific fluorescence (except autofluorescence). These findings established the feasibility of transfection of naked decoy ODN using a delivery sheet to treat vascular disease, since the delivery sheet readily changed to a gel in wet conditions. Using this transfection approach, we examined the inhibitory effect of chimeric decoy ODN on aortic dilatation. Ultrasound analysis demonstrated that treatment with chimeric decoy ODN significantly prevented the progression of elastase-induced aortic dilatation (Figure 3a) . Even 4 weeks after transfection, the inhibition of progression of AAA by chimeric decoy ODN still continued as compared to scrambled ODN (Figure 3b , Po0.005). Moreover, single transfection of NFkB decoy ODN or ets decoy ODN partially, but not significantly, inhibited the progression of experimental AAA. The chimeric decoy ODN were very potent as compared to single decoy ODN (Figure 3b , Po0.05). There was no significant difference in the progression of AAA between control (untransfected animals) and scrambled decoy ODN-treated animals. Inhibition of AAA development was readily detected using simple angiographic study. Transfection of chimeric decoy ODN inhibited aortic dilatation as compared to control and scrambled ODN as assessed by angiography (Figure 3c) .
Also, the inhibitory effect of chimeric decoy ODN on transcriptional activation of NFkB and ets was confirmed by electrophoretic mobility shift assay (EMSA). EMSA study demonstrated that activities of transcription factors, NFkB and ets, were significantly increased at 1 week after incubation with elastase, and the activation continued until at least 4 weeks. In contrast, transfection of chimeric decoy ODN significantly inhibited the activation of NFkB and ets both at 1 and 4 weeks after transfection (Figure 4a and b) .
Mechanisms of inhibitory effect of chimeric decoy ODN
Since one of the major pathogenetic mechanisms of AAA is considered to be degradation of extracellular matrix, we examined the effects of chimeric decoy ODN on MMP expression. MMP expression in the aneurysm wall was detected by gelatin zymography. Lytic bands were present at 98 kDa (MMP-9), 70 kDa (latent MMP-2), and 60 kDa (active MMP-2). Production of MMP-9 was significantly increased even at 1 day after elastase administration, although the production of both pro-MMP2 and active MMP2 was not significantly changed at 1 day. At 1 week, both MMP-9 and MMP-2 were significantly induced, whereas transfection of chimeric decoy ODN reduced the activities of both MMP-2 and MMP-9 as compared to either control or scrambled decoy ODN (Figure 5a and b). In normal aorta, these lytic bands were faintly visible. The inhibitory effect of chimeric decoy ODN on aortic dilatation was also confirmed by histological studies. In contrast, scrambled decoy ODN failed to prevent aortic dilatation ( Figure 6A ). As elastic fibers maintain the structure of the vascular wall against hemodynamic stress, resulting in prevention of aortic dilatation, we evaluated the effect of chimeric decoy ODN on the destruction of elastic fibers. Elastic van Gieson's (EVG) staining demonstrated that treatment with chimeric decoy ODN significantly inhibited the proteolysis of elastin as compared to control and scrambled decoy ODN ( Figure 6B ). Moreover, we Figure 1 Chimeric decoy strategy. GGGATTTCCC and GGAA are the consensus sequences for the NFkB-and ets-binding sites, respectively. The chimeric decoy cis element double-stranded ODN bind to free NFkB and ets, preventing transactivation of various genes described in the schema. Prevention of aortic aneurysm by chimeric decoy T Miyake et al evaluated medial VSMC in the aneurysm since they are associated with synthesis of extracellular matrix and are thought to participate in the preservation of elastin and collagen. Immunohistochemical study revealed that treatment with chimeric decoy ODN suppressed the depletion of medial VSMC as compared to scrambled decoy ODN ( Figure 6C ). Alternatively, infiltration of monocytic leukocytes into the aortic wall is also considered to be a key mechanism in the progression of AAA in animal models as well as humans. Interestingly, immunohistochemical study demonstrated that macrophage infiltration of mainly the adventitia and media was significantly inhibited by transfection of chimeric decoy ODN (Figure 7a ), while many macrophages migrated into aorta transfected with scrambled decoy ODN. Furthermore, double immunofluorescent staining revealed that migrating tissue macrophages (green color) produced both MMP-2 and MMP-9 (orange color) in the aneurysm wall (Figure 7b ).
The expression of adhesion molecules and chemotactic factors is considered to induce migration of macrophages into the vessel wall. Reverse transcription (RT)-polymerase chain reaction (PCR) analysis demonstrated that the expression levels of VCAM-1 and MCP-1 were significantly increased at 1 week after incubation with elastase. In contrast, treatment with chimeric decoy ODN significantly suppressed VCAM-1 and MCP-1 gene expression, followed by inhibition of the recruitment of macrophages (Figure 8a and b) . 
Prevention of aortic aneurysm by chimeric decoy T Miyake et al
To consider the clinical utility of chimeric decoy ODN, the laboratory data were examined at 4 weeks after transfection. As expected, single administration of chimeric decoy ODN did not result in any acute toxicity including changes in clinical pathological indices and urinalysis parameters (data not shown). There was no significant difference in body weight between rabbits treated with chimeric decoy ODN and those treated with scrambled decoy ODN, at 4 weeks after surgery. There were no significant changes in liver and renal function as compared to the data before transfection (data not shown). No alteration in histopathological, hematological, or serum chemical findings was induced.
Discussion
As human aneurysm tissues are characterized by chronic aortic wall inflammation and the progressive degradation of fibrillar matrix proteins, 6, 7 MMPs including MMP-2 and MMP-9 are thought to contribute to aneurysm development. 12, 16, 26 MMP-9, the most abundant elastolytic proteinase secreted by human AAA tissue explants in vitro, has attracted particular interest, as it is actively expressed by aneurysm-infiltrating macrophages located at the site of tissue damage in situ. 27 In addition, MMP-9 expression is correlated with aneurysm diameter. 28, 29 In contrast, patients with AAA have elevated MMP-2 levels in the vasculature remote from the aorta. 30 Thus, MMP-1, MMP-2, or MMP-9 might be necessary for aneurysmal degeneration. 29, 31, 32 Indeed, treatment with anti-inflammatory agents or MMP antagonists leads to preservation of elastin in the media and a reduction in experimental aneurysm development. [31] [32] [33] Nevertheless, inhibition of a single MMP may not be sufficient to treat AAA, since numerous MMPs may be involved in this process. Previous reports suggest that the ets family activates the transcription of genes encoding collagenase 1, stromelysin 1, and urokinase plasminogen activator, which are proteases involved in extracellular matrix degradation, [34] [35] [36] [37] whereas members of the ets family play important roles in regulating gene expression in response to multiple developmental and mitogenic signals. Thus, inhibition of ets activity might attenuate a wide range of MMP expression in AAA.
NFkB is also known to regulate transcription of MMP-1, -2, -3, and -9, [21] [22] [23] 38, 39 whereas ets regulates transcription of MMP-1, -2, and -9. Additionally, it is noteworthy Prevention of aortic aneurysm by chimeric decoy T Miyake et al that the contribution of the inflammatory process is also important in the process of AAA, because macrophages from the intravascular or retroperitoneal space, induced by inflammation, are the main cells secreting MMP-9. 10, 40, 41 Indeed, this study revealed that migrating macrophages produced both MMP-2 and MMP-9 in the aneurysm wall.
As NFkB regulates ICAM, VCAM, and ELAM, which are well-known adhesion molecules, activation of NFkB would result in macrophage migration. Our previous study also demonstrated that the inhibition of NFkB activity by decoy ODN resulted in potent inhibition of the expression of adhesion molecules such as ICAM and VCAM after balloon injury, accompanied by significant inhibition of the migration and accumulation of macrophages in the neointima. 42 Moreover, the present study demonstrated that treatment with chimeric decoy ODN inhibited the mRNA expression of VCAM-1 and MCP-1, leading to inhibition of the migration of macrophages within the aneurysm wall. In addition to ets, inhibition of NFkB activity might be a suitable target for the treatment of AAA. To inhibit both ets and NFkB simultaneously, we employed chimeric decoy ODN targeted to both ets and NFkB. Indeed, the present study clearly demonstrated that chimeric decoy ODN inhibited a broad spectrum of MMPs, the migration of macrophages, and the depletion of medial VSMC, leading to the prevention of AAA. To confirm the efficacy of the chimeric decoy ODN, we studied the inhibitory effects of single inhibition of either NFkB or ets. As expected, inhibition of either NFkB or ets partially prevented the development of AAA, whereas the chimeric decoy ODN demonstrated a further reduction in the size of AAA. Of importance, administration of chimeric decoy ODN reduced the likelihood of a systemic effect of the agent. The specificity of the inhibitory effect of chimeric decoy ODN on the progression of AAA is supported by several lines of evidence: (1) in vivo administration of chimeric decoy ODN, but not scrambled ODN, markedly inhibited dilatation of the aorta; (2) the decrease in aortic diameter in rabbits transfected with chimeric decoy ODN was associated with a decreased number of migrating macrophages. Overall, the suppression of AAA by chimeric decoy ODN could be mediated by three pathways -(1) direct inhibition of MMP gene expression driven by either the NFkB-or ets-binding site, (2) indirect inhibition of MMP secretion by migrating macrophages, and (3) inhibition of migration of macrophages which secrete MMPs. Given the successful prevention of AAA using chimeric decoy ODN in a rabbit model, the feasibility of gene therapy was also examined as a preclinical study for human gene therapy. No abnormality of biochemical parameters was observed.
Here, we demonstrated that the chimeric decoy strategy against both NFkB and ets may provide a new therapeutic strategy to treat AAA. As the present approach using a cellulose-based delivery sheet containing chimeric decoy ODN is a minimally invasive technique, further safety studies are necessary. To 
Prevention of aortic aneurysm by chimeric decoy
T Miyake et al consider the clinical usage of this strategy, the regression of AAA should also be examined, as ODN are considered to be degraded within 4 weeks. Furthermore, future study of less invasive approaches such as laparoscopy might be necessary. Also, because elastase activity is reported to be a key mechanism of human AAA development, 43, 44 the elastase-induced animal AAA model employed in this study is considered to reflect the pathogenesis of human AAA. However, since hypertension and atherosclerosis are critical in the development of AAA, it might be necessary to perform studies in more complicated models such as an angiotensin II-infused Apo E-deficient mouse model.
Materials and methods
Synthesis of ODN and selection of target sequences
The following sequences of phosphorothioate ODN were utilized:
Chimeric decoy ODN (consensus sequences are underlined):
0 -AGCTCGTATATGCACTGACGCGAGTC-5 0 ; NFkB decoy ODN (consensus sequences are underlined):
0 -GGAACTTCCCTAAAGGGAGG-5 0 ; ets-1 decoy (consensus sequences are underlined):
Synthetic ODN were washed with 70% ethanol, dried, and dissolved in sterile Tris-EDTA buffer (10 mM Tris, 1 mM EDTA). The supernatant was purified through a NAP 10 column (Pharmacia, Piscataway, NJ, USA) and quantified by spectrophotometry.
Transfection of chimera decoy ODN
Male Japanese white rabbits weighing 2.0-2.5 kg were anesthetized by intravenous injection of pentobarbital, and the infrarenal abdominal aorta was exposed by an extra-peritoneal approach. A 15 mm segment of abdominal aorta was isolated below the left renal artery without dissection of the lumbar arteries. The isolated abdominal aorta was wrapped with gauze and a plastic sheet. Aortic dilatation was induced by incubation with type I porcine pancreatic elastase (1.4 mg, 7.1 U; Sigma Chemical, St Louis, MO, USA) for 2 h around the abdominal aorta. Animals were given normal chow during the experimental period and were divided into six groups: sham, control, scrambled decoy ODN, NFkB decoy ODN, ets decoy ODN, and chimeric decoy ODN. The elastaseinduced AAA model is very popular, and is considered to be very suitable for analysis of the mechanisms of pathogenesis of AAA, as destruction of elastin is well known to play a major role in the progression of aortic dilatation. Indeed, numerous previous reports have shown that elastase activity plays an important role in the progression of AAA. 43, 44 To examine the preventive effect, transfection of decoy ODN was performed by wrapping a delivery sheet around the abdominal aorta at the same time as surgery. To create the sheet, 73 mg hydroxypropyl cellulose and 7.3 mg polyethylene glycol 400 (PEG) were dissolved in 70% ethanol, and 400 nmol decoy ODN was mixed into this solution. Drying overnight resulted in a 4 cm 2 thin sheet containing 100 nmol decoy ODN/cm 2 . This delivery sheet is easily converted to a gel in wet conditions. The sheet containing 200 nmol decoy ODN wrapped 
Ultrasound and angiographic study
Ultrasonography was used to assess the dilatation of the AAA. A cardiovascular ultrasound system (Power Vision 6000, Toshiba, Tokyo, Japan) and a linear transducer (15 MHz) were used to image the abdominal aorta noninvasively in anesthetized rabbits. Rabbits were scanned transversely and longitudinally to obtain images for measurement of the luminal diameter and the area of the lumen of the aneurysm in the segment with maximum diameter. The aortic size was measured before and after operation once a week up to 4 weeks (n ¼ 9). Angiography was also performed to evaluate dilatation of the AAA at 4 weeks after operation. Under general anesthesia, a 4F sheath was introduced into the right carotid artery, and a 3F angiographic catheter (Terumo, Tokyo, Japan) was placed in the proximal abdominal aorta under fluoroscopic guidance. Then, angiography was performed with manual injection of contrast medium.
EMSA
Rabbits were killed at 1 and 4 weeks after the operation, and nuclear extracts were prepared from transfected or untransfected aortic aneurysms. EMSA was performed using ODN containing the NFkB-binding site (5 0 -CCTTGAAGGGATTTCCCTCC-3 0 ; only sense strands are shown) or ets-binding site (5 0 -GTGCCGGGGTAG GAAGTGGGCTGGG-3 0 ; only sense strands are shown). These primers were labeled 32 P-ATP at the 3 0 end using a 3 0 end-labeling kit (Clontech Inc., Palo Alto, CA, USA). After end-labeling, 32 P-labeled ODN were purified by application to a Nick column (Pharmacia). Binding mixtures (10 ml) including 32 P-labeled primers (0.5-1 ng, 10 000-15 000 c.p.m.) and 1 mg polydeoxyinosinic-deoxycytidic acid (Sigma Chemicals) were incubated with 10 mg nuclear extract for 30 min at room temperature and then loaded onto 5% polyacrylamide gel. The gels were subjected to electrophoresis, dried, and preincubated with parallel samples for 10 min before addition of the labeled probe. Gels were analyzed by autoradiography. Experiments were repeated six times.
SDS-PAGE zymography
MMP expression in the aneurysm wall was measured in each group. Rabbits were killed at 1 week after operation, and specimens of aorta were stored at À801C until extraction. Frozen samples were homogenized in ice-cold 10 mmol/l sodium phosphate buffer containing 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, and 0.2% sodium azide, final pH 7.2. Homogenized samples were centrifuged at 15 000 r.p.m. for 10 min at 41C and the supernatant was collected. Protein extracts (30 mg) were mixed with SDS sample buffer (Invitrogen, CA, USA), and each sample was applied to 10% polyacrylamide gel containing 0.1% gelatin under nonreducing conditions. After electrophoresis, the gel was renatured in renaturing buffer (Invitrogen) for 30 min and equilibrated in developing buffer (Invitrogen) for 30 min at room temperature. After equilibration, fresh developing buffer was added and the gel was incubated overnight at 371C. The gel was stained with 0.5% Coomassie blue for 30 min and destained with destaining solution containing 10% acetic acid and 40% methanol in distilled water. Areas of protease activity appeared as unstained bands against a blue background. Experiments were repeated six times.
Histological and immunohistochemical studies
Animals were killed at 4 weeks after operation. The aorta was carefully dissected to remove adherent tissue, fixed in 10% neutral buffered formalin, and processed for routine paraffin embedding. Aortic tissue cross-sections (6 mm) were stained with both hematoxylin and eosin (HE) and EVG in a standard manner. To evaluate residual mature elastin, the area of elastic fibers in EVG-stained sections was calculated by quantitative morphometric analysis with a computerized sketching program. Results were expressed as a percentage of the total area of the cross-section. Experiments were repeated six times.
Mouse monoclonal antibodies against rabbit macrophages (RAM11, Dako, CA, USA) and a-smooth muscle actin (Clone 1A4, DAKO) were used to analyze macrophage recruitment and depletion of VSMC in the media in rabbit experimental AAA. For negative control experiments, the primary antibody was omitted. Immunohistochemical staining was performed using the immunoperoxidase avidin-biotin complex system. Then, 5 mm sections were deparaffinized, rehydrated before blocking endogenous peroxidase activity with 3% hydrogen peroxidase, and preincubated with 5% normal horse serum in sodium phosphate-buffered saline (PBS) for 30 min. Diluted primary antibodies (1:50) were then applied to the sections, and these sections were incubated overnight at 41C. With intervening washing in PBS, they were serially incubated with biotinylated antimouse IgG (Vector Laboratories, Burlingame, CA, USA) in PBS for 30 min and avidin-biotinylated horseradish peroxidase complex in PBS for 30 min, according to the manufacturer's specifications (Vectastain Elite ABC kit, Vector Laboratories). Immune complexes were localized using 0.05% 3,3 0 -diaminobenzidine (DAB, Vector Laboratories), and slides were counterstained with hematoxylin. Experiments were repeated six times.
To determine the cells secreting MMPs within the aneurysm wall, double immunofluorescent staining for MMP and macrophages was also performed. Polyclonal goat antibodies for human MMP-2 and MMP-9 (15 mg/ml, R&D Systems, Minneapolis, MN, USA) and mouse monoclonal antibody against rabbit macrophages were used. Protein reacting with primary antibodies was visualized with fluorescence-conjugated anti-mouse IgG (Alexa 488, Invitrogen) for macrophages and antigoat IgG (Alexa 546) for MMP. The images were visualized using fluorescence microscopy. 45 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; sense: 5 0 -ACGGTGCACGCCATCACTGCC-3 0 , antisense: 5 0 -GC CTGCTTCACCACCTTCTTG-3 0 ; 266 bp), 46 were used. Equal amounts (0.1 mg) of RNA from each sample were reverse transcribed into cDNA for 30 min at 551C. PCR amplification was performed under the following conditions: denaturation for 15 s at 941C annealing for 30 s at 551C, elongation for 1 min at 681C for 25 cycles. PCR products were run on 1% agarose gels and stained with ethidium bromide. Expression of VCAM-1 and MCP-1 was determined relative to the expression of GAPDH. Experiments were repeated five times.
Statistical analysis
All values are expressed as mean7s.e.m. Analysis of variance with ANOVA was used to determine the significance of differences in multiple comparisons. Po0.05 was considered significant.
